Krajina: Austrália
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
Ginkgo biloba, Quantity: 50 mg (Equivalent: Ginkgo biloba, Qty 2.5 g; Equivalent: Ginkgo flavonglycosides, Qty 12 mg; Equivalent: Ginkgolides and bilobalide, Qty 3 mg)
H C L Manufacturers Pty Ltd
Ginkgo biloba
Tablet, film coated
Excipient Ingredients: colloidal anhydrous silica; hypromellose; crospovidone; calcium hydrogen phosphate dihydrate; povidone; microcrystalline cellulose; magnesium stearate; macrogol 400; Carnauba Wax
Oral
N/A
Medicine Listed (Export Only)
(S1) This Schedule is intentionally blank
Ginkgo Biloba can also be used to temporarily relieve tinnitus (ringing in the ears) and has a powerful antioxidant action. [PERI] to the extremities such as the hands and feet. Helps maintain blood flow to the extremities such as the hands, legs and feet. Protects and helps mantain health of capillaries. [PERI] to relieve cold hands and feet. [PERI] and promoting general health. Assisting in the maintenance of blood flow in the hands, feet and legs. Helps maintain blood circulation to the peripheral areas of the body such as the legs, hands and feet
Visual Identification: Small, round, biconvex, beige brown mottled, clear film-coated tablet; Container Type: Bottle; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2000-03-28